Minimed Group, INC 8-K filings

MiniMed Group, Inc. reports the resignation of its Senior Vice President, General Counsel, and Corporate Secretary, Courtney Nelson Wills, effective September 25, 2026.

MiniMed Group, Inc. announced an expansion of its Board of Directors with two new appointments and set the date and record date for its 2026 Annual Meeting of Stockholders.

MiniMed announced record fiscal year 2026 net sales exceeding $3 billion, with Q4 sales up 15.6% year-over-year, driven by international markets and new product clearances.

MiniMed Group, Inc. reports the resignation of director Brett Wall and the appointment of Scott Cundy to the Board of Directors.

MiniMed Group, Inc. disclosed that its parent company, Medtronic plc, experienced a cybersecurity incident involving unauthorized access to IT systems, with no expected material impact on MiniMed's business or financial results.

MiniMed Group, Inc. approved new severance and change of control plans for its executives, enhancing benefits for eligible terminations.

MiniMed Group, Inc. announced FDA clearance for its MiniMed Flex insulin pump several months earlier than anticipated, leading to a $157 million charge related to a development funding agreement.